Portal cavernoma cholangiopathy (notice n° 174848)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02067cam a2200301 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250112040018.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Malezieux, Émilie |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Portal cavernoma cholangiopathy |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2023.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 60 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Portal cavernoma cholangiopathy is identified by the presence of a biliary tract anomaly in a portal cavernoma context. Its pathophysiology is complex and is not limited to simple compressive phenomena. It is frequently identified during imaging, but is only symptomatic in 20 percent of cases. The clinical manifestations are those of any biliary obstruction: jaundice, lithiasis, acute cholitis. MRI is the best imaging tool for assessing the exact delineation of the varicose collaterals, the extension of the thrombus, and the damage to the bile ducts. Treatments, which are only interventional, should be reserved for symptomatic conditions. Endoscopy is of primary importance in order to remove the biliary obstacle via ERCP. Interventional radiology, via portal recanalization with or without TIPS, and surgical portosystemic shunts enable both the removal of portal hypertension, and the treatment of its other consequences (esophageal variceal rupture, ascites, and so on). In exceptional cases, liver transplantation may be proposed in cases of secondary biliary cirrhosis. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | interventional radiology |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | portal cavernoma cholangiopathy |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | physiopathology |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | interventional endoscopy |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | interventional radiology |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | portal cavernoma cholangiopathy |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | physiopathology |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | interventional endoscopy |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Meunier, Lucy |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sanavio, Mathilde |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Guiu, Boris |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Debourdeau, Antoine |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Hépato-Gastro & Oncologie Digestive | 30 | 4 | 2023-04-05 | p. 403-411 | 2115-3310 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/journal-hepato-gastro-et-oncologie-digestive-2023-4-page-403?lang=en">https://shs.cairn.info/journal-hepato-gastro-et-oncologie-digestive-2023-4-page-403?lang=en</a> |
Pas d'exemplaire disponible.
Réseaux sociaux